ClinicalTrials.Veeva

Menu

Molecular Pituitary Imaging Using 18F-FET PET (FET-pit-PET)

U

University of Cambridge

Status

Enrolling

Conditions

Pituitary Adenoma

Treatments

Diagnostic Test: 18F-Fluoro-ethyl-tyrosine (FET) PET

Study type

Interventional

Funder types

Other

Identifiers

NCT06584123
24/LO/0542

Details and patient eligibility

About

The goal of this single centre pilot study is to explore whether 18F-fluoro-ethyl-tyrosine PET (FET-PET) yields comparable findings to 11C-methionine PET (Met-PET) for the localisation of pituitary tumours.

Full description

Up to 20 patients with pituitary adenomas (PA) who have previously undergone 11C-methionine PET (Met-PET) as part of routine clinical care will undergo 18F-fluoroethyltyrosine PET (FET-PET). Patients with newly diagnosed PA or residual/recurrent pituitary tumours following previous treatment will be eligible for recruitment to the study.

Quantitative and qualitative analyses will be performed to assess whether MET-PET and FET-PET yield comparable findings in patients with newly diagnosed or recurrent PA.

Enrollment

20 estimated patients

Sex

All

Ages

18 to 100 years old

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion criteria

  • Participant is willing and able to give informed consent for participation in the study
  • Male or female, age 18 or above
  • Presence of pituitary adenoma suspected on the basis of clinical/biochemical and/or radiological findings
  • Previous 11C-Met-PET/CT

Exclusion criteria

  • Inability to give informed consent
  • Pregnancy or suspected pregnancy
  • Inability to lie supine for 30-60 minutes
  • Patient body habitus above scanner dimensions
  • Known allergy to intravenous radiographic contrast agents

Trial design

Primary purpose

Diagnostic

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

20 participants in 1 patient group

Study cohort
Experimental group
Description:
All patient's enrolled in the study will undergo an 18F-FET-PET
Treatment:
Diagnostic Test: 18F-Fluoro-ethyl-tyrosine (FET) PET

Trial contacts and locations

1

Loading...

Central trial contact

James MacFarlane

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems